Catalog Home Page

Metabolomics in hypertension

Nikolic, S.B., Sharman, J.E., Adams, M.J.ORCID: 0000-0002-7743-4515 and Edwards, L.M. (2014) Metabolomics in hypertension. Journal of Hypertension, 32 (6). pp. 1159-1169.

Link to Published Version: https://doi.org/10.1097/HJH.0000000000000168
*Subscription may be required

Abstract

Hypertension is the most prevalent chronic medical condition and a major risk factor for cardiovascular morbidity and mortality. In the majority of hypertensive cases, the underlying cause of hypertension cannot be easily identified because of the heterogeneous, polygenic and multi-factorial nature of hypertension. Metabolomics is a relatively new field of research that has been used to evaluate metabolic perturbations associated with disease, identify disease biomarkers and to both assess and predict drug safety and efficacy. Metabolomics has been increasingly used to characterize risk factors for cardiovascular disease, including hypertension, and it appears to have significant potential for uncovering mechanisms of this complex disease. This review details the analytical techniques, pre-analytical steps and study designs used in metabolomics studies, as well as the emerging role for metabolomics in gaining mechanistic insights into the development of hypertension. Suggestions as to the future direction for metabolomics research in the field of hypertension are also proposed.

Item Type: Journal Article
Publisher: Wolters Kluwer Health | Lippincott Williams & Wilkins
Copyright: © 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins
URI: http://researchrepository.murdoch.edu.au/id/eprint/53606
Item Control Page Item Control Page